Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells

The advent of induced pluripotent stem cells (iPSCs) together with recent advances in genome editing, microphysiological systems, tissue engineering and xenograft models present new opportunities for the investigation of hematological diseases and cancer in a patient-specific context. Here we review...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Huensuk, Schaniel, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172418/
https://www.ncbi.nlm.nih.gov/pubmed/30323816
http://dx.doi.org/10.3389/fimmu.2018.02243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172418/
https://www.ncbi.nlm.nih.gov/pubmed/30323816
http://dx.doi.org/10.3389/fimmu.2018.02243

Ejemplares similares